ASPE Issue Brief

This study sought to identify the amount of overlap among three methods of identifying people with dementia, and to obtain national estimates of the number of people with dementia. It also explored key characteristics of people identified as having dementia by the various methods, to understand potential causes and implications of differences for policy and practice.

Functional Trajectories at the End of Life for Individuals with Dementia: Final Report Ila H. Broyles, PhD; Amy Huebeler, BS; Ira Dave, MS; Emily Graf, BA; Qinghua Li, PhD; Lauren Palmer, PhD; Zhanlian Feng, PhD; and Sarita L.

Dementia, including Alzheimer’s disease and related disorders, is a neurocognitive disease affecting an individual’s cognitive function and behavior. Dementia is a leading cause of death and is particularly prevalent at the end of life (EOL) in older adults.

The main purpose of this study was to investigate the barriers to and facilitators of licensing, credentialing, and insurance reimbursement for substance use disorder (SUD) treatment providers across the nation.

Child support programs use various strategies called “enforcement tools” to collect critical monetary support for custodial families from noncustodial parents. The enforcement of child support is intended to encourage parental responsibility so that children receive financial, emotional, and medical support from both parents, even when they live in separate households.

Westat Printer Friendly Version in PDF Format (3 PDF pages)

As the opioid epidemic has evolved into a national crisis, the need for treatment has increased greatly. Medication-assisted treatment (MAT) is a “whole-patient” approach to the treatment of opioid use disorder (OUD) that combines the use of medications and psychosocial supports, such as therapy, counseling, self-help groups, and case management.

This brief outlines actionable steps that program designers at the federal, state, or local level can take to build or use aligned measures across programs in ways that can improve program management and increase service coordination.

By statute, the majority of patients with end-stage renal disease (ESRD) are eligible for Medicare, regardless of age. Kidney transplantation is ultimately considered the best treatment for ESRD, but ESRD-related eligibility for Medicare coverage extends for only 36 months post-transplant.

Between 1996 and 2013, there was a 54% decrease in the incidence of diabetes-related end-stage renal disease (ESRD-DM) in American Indian and Alaska Native (AI/ AN) populations. This decline has occurred since the Special Diabetes Program for Indians (SDPI) was established in 1997.